Use of LHRH-agonists as adjuvant therapy for breast cancer

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.12, Iss.8, 2008-08, pp. : 1065-1071

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Breast cancer adjuvant therapy use increases in the US

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 367, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Adjuvant Luteinising Hormone-Releasing Hormone (LHRH)--Agonist Therapy in Prostate Cancer

By Kaisary A.V. Jarmulowicz M.

UroOncology, Vol. 3, Iss. 2, 2003-06 ,pp. : 51-62

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Extend use of adjuvant therapy in breast cancer?

Inpharma, Vol. 1, Iss. 1277, 2001-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Aminoglutethimide adjuvant therapy in breast cancer

Inpharma, Vol. 1, Iss. 1322, 2002-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Controversies in breast cancer: adjuvant and neoadjuvant therapy

By Montemurro Filippo Redana Stefania Valabrega Giorgio Aglietta Massimo

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 7, 2005-06 ,pp. : 1055-1072

Informa Healthcare

Access to resources Recommend Favorite